Bnp Paribas Asset Management Holding S.A. Procept Bio Robotics Corp Transaction History
Bnp Paribas Asset Management Holding S.A.
- $40.3 Billion
- Q4 2024
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 494,717 shares of PRCT stock, worth $29.7 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
494,717
Previous 510,653
3.12%
Holding current value
$29.7 Million
Previous $40.9 Million
2.64%
% of portfolio
0.1%
Previous 0.1%
Shares
7 transactions
Others Institutions Holding PRCT
# of Institutions
294Shares Held
40.1MCall Options Held
196KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.14MShares$309 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$209 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$105 Million0.05% of portfolio
-
Loomis Sayles & CO L P1.21MShares$72.5 Million0.12% of portfolio
-
State Street Corp Boston, MA1.19MShares$71.4 Million0.0% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.68B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...